T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Eastman Chemical
EMN
$8.43B
| $21.2M | ﹤0.01% |
210,663
-1,212,674
| -85% | -$134M |
|
1277
Huntington Ingalls Industries
HII
$12.8B
| $21.1M | ﹤0.01% |
109,542
+15,600
| +17% | +$3.16M |
|
1278
Blackstone Mortgage Trust
BXMT
$2.44B
| $21M | ﹤0.01% |
694,239
-128,537
| -16% | -$4.08M |
|
1279
Array Technologies
ARRY
$796M
| $21M | ﹤0.01% |
1,133,782
-5,228,701
| -82% | -$86.7M |
|
|
INVX
1280
Innovex International
INVX
$2.15B
| $21M | ﹤0.01% |
832,517
-494,097
| -37% | -$13.1M |
|
1281
Ponce Financial Group
PDLB
$501M
| $20.9M | ﹤0.01% |
2,013,005
-2,824
| -0.1% | -$27.6K |
|
1282
Aspen Aerogels
ASPN
$504M
| $20.8M | ﹤0.01% |
452,830
-54,254
| -11% | -$2.15M |
|
1283
Pacira BioSciences
PCRX
$924M
| $20.8M | ﹤0.01% |
371,588
-2,064
| -0.6% | -$119K |
|
1284
American Airlines Group
AAL
$9.97B
| $20.6M | ﹤0.01% |
1,005,069
-20,369
| -2% | -$413K |
|
|
LBPH
1285
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $20.4M | ﹤0.01% |
2,285,290
-1,999
| -0.1% | -$18.4K |
|
1286
J.M. Smucker
SJM
$12.9B
| $20.3M | ﹤0.01% |
169,496
-3,396
| -2% | -$432K |
|
1287
Dynatrace
DT
$14.7B
| $20.3M | ﹤0.01% |
286,042
+19,063
| +7% | +$1.25M |
|
1288
iRhythm Holdings
IRTC
$4.06B
| $20M | ﹤0.01% |
342,092
-227,617
| -40% | -$12.1M |
|
1289
Robert Half
RHI
$4.48B
| $20M | ﹤0.01% |
199,572
-632
| -0.3% | -$61.9K |
|
1290
Pultegroup
PHM
$24.9B
| $20M | ﹤0.01% |
434,993
-8,307
| -2% | -$432K |
|
1291
iShares Core MSCI EAFE ETF
IEFA
$196B
| $19.9M | ﹤0.01% |
268,205
+50,253
| +23% | +$3.82M |
|
1292
Whirlpool
WHR
$2.79B
| $19.9M | ﹤0.01% |
97,645
-2,707
| -3% | -$594K |
|
1293
Knowles
KN
$3.23B
| $19.7M | ﹤0.01% |
1,051,453
-1,251,942
| -54% | -$24.5M |
|
1294
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $19.5M | ﹤0.01% |
185,341
| – | – |
|
1295
Lumen
LUMN
$6.6B
| $19.5M | ﹤0.01% |
1,577,091
-13,713
| -0.9% | -$172K |
|
1296
Henry Schein
HSIC
$10B
| $19.5M | ﹤0.01% |
256,433
-11,373
| -4% | -$875K |
|
1297
Service Corp International
SCI
$11.3B
| $19.5M | ﹤0.01% |
323,827
-11,074
| -3% | -$674K |
|
|
SWTX
1298
DELISTED
SpringWorks Therapeutics
SWTX
| $19.5M | ﹤0.01% |
307,407
-1,530
| -0.5% | -$118K |
|
1299
Stepan Co
SCL
$1.48B
| $19.5M | ﹤0.01% |
172,438
-33,679
| -16% | -$3.92M |
|
1300
Arcutis Biotherapeutics
ARQT
$3.25B
| $19.4M | ﹤0.01% |
813,694
-111,264
| -12% | -$2.54M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.